Binocrit injection is used to treat anemia in specific adult patients.
How Binocrit Works
Binocrit is primarily used to manage anemia stemming from particular conditions. This means it helps to increase the red blood cell count in the body. It does so by acting like the natural hormone erythropoietin.
Target Group: Adults with Myelodysplastic Syndromes
Specifically, Binocrit is prescribed for:
- Adults diagnosed with myelodysplastic syndromes (MDS). These are disorders where the bone marrow doesn't produce enough healthy blood cells.
- Patients with MDS are categorized as low or intermediate risk for developing acute myeloid leukemia (AML).
- The treatment is usually for those who also have low levels of erythropoietin, a natural hormone that stimulates red blood cell production.
What it Treats
In summary, Binocrit focuses on treating anemia in adults with myelodysplastic syndromes who are at low or intermediate risk and have low erythropoietin levels.
Why is this important?
Anemia can lead to:
- Fatigue and weakness
- Shortness of breath
- Dizziness
- Other symptoms that affect a patient's quality of life
Binocrit aims to increase red blood cell count, thus alleviating these symptoms.
Important note from the reference:
- Binocrit is used when patients are at low or intermediate risk of developing acute myeloid leukaemia and have low levels of the natural hormone erythropoietin.
